CoChat

Antimicrobial resistance in methicillin-resistant staphylococcus aureus

Ali Alghamdi, Bandar, Al-Johani, Intisar, Al-Shamrani, Jawhra M., Musamed Alshamrani, Hussein, Al-Otaibi, Bandar G., Almazmomi, Kholod, Yusnoraini Yusof, Nik · 2023 · Saudi Journal of Biological Sciences
Cited by 143

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

In the medical community, antibiotics are revered as a miracle because they stop diseases brought on by pathogenic bacteria. Antibiotics have become the cornerstone of contemporary medical advancements ever since penicillin was discovered. Antibiotic resistance developed among germs quickly, placing a strain in the medical field. Methicillin-resistant Staphylococcus aureus (MRSA), Since 1961, has emerged as the major general antimicrobial resistant bacteria (AMR) worldwide. MRSA can easily transmit across the hospital system and has mostly gained resistance to medications called beta-lactamases. This enzyme destroys the cell wall of beta-lactam antibiotics resulting in resistance against that respective antibiotic. Daptomycin, linezolid and vancomycin were previously used to treat MRSA infections. However, due to mutations and Single nucleotide polymorphisms (SNPs) in Open reading frames (ORFs) and SCCmec machinery of respective antibody, MRSA developed resistance against those antibiotics. The MRSA strains (USA300, CC398, CC130 etc.), when their pan-genomes were analyzed were found the genes involved in invoking resistance against the antibiotics as well as the epidemiology of that respective strain. PENC (penicillin plus potassium clavulanate) is the new antibiotic showing potential in treatment of MRSA though it is itself resistant against penicillin alone. In this review, our main focus is on mechanism of development of AMR in MRSA, how different ORFs are involved in evoking resistance in MRSA and what is the core-genome of different antimicrobial resistant MRSA.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.sjbs.2023.103604

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 95

  1. Abraham, 1988, An enzyme from bacteria able to destroy penicillin. 1940, Rev. Infect. Dis., 10, 677
  2. Ahmed, 2018, Vancomycin-resistant enterococci: a review of antimicrobial resistance mechanisms and perspectives of human and animal health, Microb. Drug Resist., 24, 590, 10.1089/mdr.2017.0147 · DOI · Paper page
  3. Aklilu, 2013, Molecular epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) among veterinary students and personnel at a veterinary hospital in Malaysia, Vet. Microbiol., 164, 352, 10.1016/j.vetmic.2013.02.030 · DOI
  4. Alam, 2015, Transmission and microevolution of USA300 MRSA in US households: evidence from whole-genome sequencing, J. Mol. Biol., 6, e00054
  5. Barlow, 2009, What antimicrobial resistance has taught us about horizontal gene transfer, Journal of Horizontal Gene Transfer, 397, 10.1007/978-1-60327-853-9_23 · DOI · Paper page
  6. Bayer, 2014, Heterogeneity of mprF sequences in methicillin-resistant Staphylococcus aureus clinical isolates: role in cross-resistance between daptomycin and host defense antimicrobial peptides, Journal of Antimicrobial agents chemotherapy, 58, 7462, 10.1128/AAC.03422-14 · DOI
  7. Bayer, 2015, Frequency and distribution of single-nucleotide polymorphisms within mprF in methicillin-resistant Staphylococcus aureus clinical isolates and their role in cross-resistance to daptomycin and host defense antimicrobial peptides, Antimicrobial agents, 59, 4930, 10.1128/AAC.00970-15 · DOI · Paper page
  8. Berger-Bächi, 2002, Factors influencing methicillin resistance in staphylococci, Arch. Microbiol., 178, 165, 10.1007/s00203-002-0436-0 · DOI · Paper page
  9. Bertsche, 2013, Increased cell wall teichoic acid production and D-alanylation are common phenotypes among daptomycin-resistant methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates, PLoS One, 8, e67398, 10.1371/journal.pone.0067398 · DOI · Paper page
  10. Biedenbach, 2010, Stability of linezolid activity in an era of mobile oxazolidinone resistance determinants: results from the 2009 Zyvox® Annual Appraisal of Potency and Spectrum program, Diagnostic microbiology infectious disease, 68, 459, 10.1016/j.diagmicrobio.2010.09.018 · DOI
  11. Bitrus, 2017, In vitro transfer of methicillin resistance determinants mecA from methicillin resistant Staphylococcus aureus (MRSA) to methicillin susceptible Staphylococcus aureus (MSSA), BMC Microbiol., 17, 1, 10.1186/s12866-017-0994-6 · DOI
  12. Boucher, 2007, Perspectives on daptomycin resistance, with emphasis on resistance in Staphylococcus aureus, Clin. Infect. Dis., 45, 601, 10.1086/520655 · DOI · Paper page
  13. Boumghar-Bourtchaï, 2009, Influence of recombination on development of mutational resistance to linezolid in Enterococcus faecalis JH2-2, Antimicrobial agents chemotherapy, 53, 4007, 10.1128/AAC.01633-08 · DOI
  14. Brickner, 1996, Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections, J. Med. Chem., 39, 673, 10.1021/jm9509556 · DOI · Paper page
  15. Brown, 2021, Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK, JAC-antimicrobial resistance, 3, p. dlaa114, 10.1093/jacamr/dlaa114 · DOI · Paper page
  16. Cameron, 2016, Vancomycin susceptibility in methicillin-resistant Staphylococcus aureus is mediated by YycHI activation of the WalRK essential two-component regulatory system, Sci. Rep., 6, 1, 10.1038/srep30823 · DOI
  17. Castro, 2020, Detection of heterogeneous vancomycin intermediate resistance in MRSA isolates from Latin America, J. Antimicrob. Chemother., 75, 2424, 10.1093/jac/dkaa221 · DOI
  18. Castro, 2022, Multiomics characterization of methicillin-resistant Staphylococcus aureus (MRSA) isolates with heterogeneous intermediate resistance to vancomycin (hVISA) in Latin America, J. Antimicrob. Chemother.
  19. Chambers, 1997, Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications, Clin. Microbiol. Rev., 10, 781, 10.1128/CMR.10.4.781 · DOI · Paper page
  20. Chen, 2018, Using core-genome multilocus sequence typing to monitor the changing epidemiology of methicillin-resistant Staphylococcus aureus in a teaching hospital, Clin. Infect. Dis., 67, S241, 10.1093/cid/ciy644 · DOI · Paper page
  21. Chongtrakool, 2006, Staphylococcal cassette chromosome mec (SCC mec) typing of methicillin-resistant Staphylococcus aureus strains isolated in 11 Asian countries: a proposal for a new nomenclature for SCC mec elements, Antimicrobial agents, 50, 1001, 10.1128/AAC.50.3.1001-1012.2006 · DOI · Paper page
  22. Craft, 2019, Methicillin-resistant Staphylococcus aureus (MRSA): antibiotic-resistance and the biofilm phenotype, MedChemComm, 10, 1231, 10.1039/C9MD00044E · DOI · Paper page
  23. Cuny, 2015, Prevalence of the immune evasion gene cluster in Staphylococcus aureus CC398, Vet. Microbiol., 177, 219, 10.1016/j.vetmic.2015.02.031 · DOI
  24. David, 2014, Replacement of HA-MRSA by CA-MRSA infections at an academic medical center in the midwestern United States, 2004–5 to 2008, PLoS One, 9, e92760, 10.1371/journal.pone.0092760 · DOI
  25. Diep, 2008, The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus, J Infect Dis, 197, 1523, 10.1086/587907 · DOI · Paper page
  26. Dixit, 2019, Antimicrobial resistance: progress in the decade since emergence of New Delhi metallo-β-lactamase in India, Indian journal of community medicine: official publication of Indian Association of Preventive Social Medicine, 44, 4, 10.4103/ijcm.IJCM_217_18 · DOI · Paper page
  27. Endimiani, 2011, Emergence of linezolid-resistant Staphylococcus aureus after prolonged treatment of cystic fibrosis patients in Cleveland, Ohio, Antimicrobial agents chemotherapy, 55, 1684, 10.1128/AAC.01308-10 · DOI · Paper page
  28. Enright, 2002, The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA), Proc. Natl. Acad. Sci., 99, 7687, 10.1073/pnas.122108599 · DOI · Paper page
  29. Ernst, 2009, The bacterial defensin resistance protein MprF consists of separable domains for lipid lysinylation and antimicrobial peptide repulsion, PLoS Pathog., 5, e1000660, 10.1371/journal.ppat.1000660 · DOI · Paper page
  30. Gao, 2022, Spreading of cfr-Carrying Plasmids among Staphylococci from Humans and Animals., 10, e02461
  31. Gómez, 2015, High prevalence of methicillin-resistant Staphylococcus aureus (MRSA) carrying the mecC gene in a semi-extensive red deer (Cervus elaphus hispanicus) farm in Southern Spain, Vet. Microbiol., 177, 326, 10.1016/j.vetmic.2015.03.029 · doi:10.1016/j.vetmic.2015.03.029
  32. Gómez, 2016, Detection of MRSA ST3061-t843-mecC and ST398-t011-mecA in white stork nestlings exposed to human residues, J. Antimicrob. Chemother., 71, 53, 10.1093/jac/dkv314 · DOI
  33. Gómez, 2021, Genomic analysis of Staphylococcus aureus of the lineage CC130, including mecC-carrying MRSA and MSSA isolates recovered of animal, human, and environmental origins, Front. Microbiol., 12, 10.3389/fmicb.2021.655994 · DOI
  34. Gu, 2013, The emerging problem of linezolid-resistant Staphylococcus, J. Antimicrob. Chemother., 68, 4, 10.1093/jac/dks354 · DOI · Paper page
  35. Hanssen, 2006, SCC mec in staphylococci: genes on the move, FEMS Immunology, 46, 8, 10.1111/j.1574-695X.2005.00009.x · DOI · Paper page
  36. Harrison, 2017, Genomic surveillance reveals low prevalence of livestock-associated methicillin-resistant Staphylococcus aureus in the East of England, Sci. Rep., 7, 1, 10.1038/s41598-017-07662-2 · DOI
  37. Hibbitts, 2018, Emerging nanomedicine therapies to counter the rise of methicillin-resistant Staphylococcus aureus, J. Mater., 11, 321, 10.3390/ma11020321 · DOI
  38. Humphries, 2013, A current perspective on daptomycin for the clinical microbiologist, Clin. Microbiol. Rev., 26, 759, 10.1128/CMR.00030-13 · DOI · Paper page
  39. Hutchings, 2019, Antibiotics: past, present and future, Curr. Opin. Microbiol., 51, 72, 10.1016/j.mib.2019.10.008 · DOI · Paper page
  40. Iguchi, 2016, Rapid acquisition of linezolid resistance in methicillin-resistant Staphylococcus aureus: role of hypermutation and homologous recombination, PLoS One, 11, e0155512, 10.1371/journal.pone.0155512 · DOI · Paper page
  41. Ito, 2003, Insights on antibiotic resistance of Staphylococcus aureus from its whole genome: genomic island SCC, Drug Resist. Updat., 6, 41, 10.1016/S1368-7646(03)00003-7 · DOI · Paper page
  42. Jamrozy, 2016, Pan-genomic perspective on the evolution of the Staphylococcus aureus USA300 epidemic, Microb. Genomics, 2, 10.1099/mgen.0.000058 · DOI · Paper page
  43. Jolivet-Gougeon, 2011, Bacterial hypermutation: clinical implications, J. Med. Microbiol., 60, 563, 10.1099/jmm.0.024083-0 · DOI · Paper page
  44. Jones, 2008, Failures in clinical treatment of Staphylococcus aureus infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding, Antimicrobial agents chemotherapy, 52, 269, 10.1128/AAC.00719-07 · DOI · Paper page
  45. Kapoor, 2017, Action and resistance mechanisms of antibiotics: A guide for clinicians, J. Anaesthesiol. Clin. Pharmacol., 33, 300, 10.4103/joacp.JOACP_349_15 · DOI · Paper page
  46. Kennedy, 2010, Complete nucleotide sequence analysis of plasmids in strains of Staphylococcus aureus clone USA300 reveals a high level of identity among isolates with closely related core genome sequences, J. Clin. Microbiol., 48, 4504, 10.1128/JCM.01050-10 · DOI
  47. King, 2017, The mechanisms of resistance to b-lactam antibiotics, Handbook of antimicrobial resistance, 177, 10.1007/978-1-4939-0694-9_10 · DOI
  48. Kırmusaoğlu, S. and Enany, S. (Eds.), 2017. MRSA and MSSA: The mechanism of methicillin resistance and the influence of methicillin resistance on biofilm phenotype of Staphylococcus aureus. Antibiotic Resistance in Staphylococcus aureus, 2017: p. 25-41. · DOI
  49. Kırmusaoğlu, S., Gareayaghi, N. and Kocazeybek, B.S. 2019. Introductory chapter: the action mechanisms of antibiotics and antibiotic resistance. In: Antimicrobials, antibiotic resistance, antibiofilm strategies and activity methods. 2019, IntechOpen. · doi:10.5772/intechopen.85211
  50. Li, 2016, Increased community-associated infections caused by panton-valentine leukocidin–negative MRSA, Shanghai, 2005–2014, Emerg. Infect. Dis., 22, 1988, 10.3201/eid2211.160587 · DOI
  51. Li, 2018, The changing pattern of population structure of Staphylococcus aureus from bacteremia in China from 2013 to 2016: ST239-030-MRSA replaced by ST59-t437, Front. Microbiol., 9, 332, 10.3389/fmicb.2018.00332 · DOI · Paper page
  52. Livermore, 2002, Multicentre evaluation of the VITEK 2 Advanced Expert System for interpretive reading of antimicrobial resistance tests, J. Antimicrob. Chemother., 49, 289, 10.1093/jac/49.2.289 · doi:10.1093/jac/49.2.289
  53. Lobritz, 2003, Recombination proficiency influences frequency and locus of mutational resistance to linezolid in Enterococcus faecalis, Antimicrobial agents chemotherapy, 47, 3318, 10.1128/AAC.47.10.3318-3320.2003 · DOI · Paper page
  54. Locke, 2009, Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700), Antimicrobial agents chemotherapy, 53, 5265, 10.1128/AAC.00871-09 · DOI · Paper page
  55. Lozano, 2020, Human mecC-carrying MRSA: Clinical implications and risk factors, Microorganisms, 8, 1615, 10.3390/microorganisms8101615 · DOI
  56. Lv, 2021, A review of artificial intelligence applications for antimicrobial resistance, Biosafety Health, 3, 22, 10.1016/j.bsheal.2020.08.003 · DOI · Paper page
  57. Maarouf, 2021, Prevalence and mechanisms of linezolid resistance among staphylococcal clinical isolates from Egypt, European Journal of Clinical Microbiology Infectious Diseases, 40, 815, 10.1007/s10096-020-04045-w · DOI
  58. Meka, 2004, Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA, J Infect Dis, 190, 311, 10.1086/421471 · DOI · Paper page
  59. Mishra, 2013, Emergence of daptomycin resistance in daptomycin-naive rabbits with methicillin-resistant Staphylococcus aureus prosthetic joint infection is associated with resistance to host defense cationic peptides and mprF polymorphisms, PLoS One, 8, e71151, 10.1371/journal.pone.0071151 · DOI · Paper page
  60. Mishra, 2014, Phenotypic and genotypic characterization of daptomycin-resistant methicillin-resistant Staphylococcus aureus strains: relative roles of mprF and dlt operons, PLoS One, 9, e107426, 10.1371/journal.pone.0107426 · DOI
  61. Misiura, 2013, Roles of two large serine recombinases in mobilizing the methicillin-resistance cassette SCCmec, Mol. Microbiol., 88, 1218, 10.1111/mmi.12253 · DOI · Paper page
  62. Monecke, 2016, Diversity of Staphylococcus aureus isolates in European wildlife, PLoS One, 11, e0168433, 10.1371/journal.pone.0168433 · DOI
  63. Montravers, 2021, Cotrimoxazole and clindamycin in skin and soft tissue infections, Curr. Opin. Infect. Dis., 34, 63, 10.1097/QCO.0000000000000698 · doi:10.1097/qco.0000000000000698
  64. Nandhini, 2022, Recent Developments in Methicillin-Resistant Staphylococcus aureus (MRSA) Treatment: A Review, Antibiotics, 11, 606, 10.3390/antibiotics11050606 · DOI · Paper page
  65. Naz, 2022, The epidemiological and pangenome landscape of Staphylococcus aureus and identification of conserved novel candidate vaccine antigens, Curr. Proteomics, 19, 114, 10.2174/1570164618666210212122847 · DOI
  66. Nicolaou, 2018, A brief history of antibiotics and select advances in their synthesis, J. Antibiot., 71, 153, 10.1038/ja.2017.62 · DOI · Paper page
  67. Ohlsen, 2003, Impact of antibiotics on conjugational resistance gene transfer in Staphylococcus aureus in sewage, Environ. Microbiol., 5, 711, 10.1046/j.1462-2920.2003.00459.x · DOI · Paper page
  68. Otter, 2006, Nosocomial transmission of community-associated meticillin-resistant Staphylococcus aureus: an emerging threat, Lancet Infect. Dis., 6, 753, 10.1016/S1473-3099(06)70636-3 · DOI
  69. Otto, 2010, Staphylococcus aureus toxin gene hitchhikes on a transferable antibiotic resistance element, Journal of Virulence, 1, 49, 10.4161/viru.1.1.10453 · DOI
  70. Paterson, 2014, The emergence of mecC methicillin-resistant Staphylococcus aureus, Trends Microbiol., 22, 42, 10.1016/j.tim.2013.11.003 · DOI
  71. Peacock, 2015, Mechanisms of methicillin resistance in Staphylococcus aureus, Annu. Rev. Biochem, 84, 577, 10.1146/annurev-biochem-060614-034516 · DOI · Paper page
  72. Perlaza-Jiménez, 2022, A Structurally Characterized Staphylococcus aureus Evolutionary Escape Route from Treatment with the Antibiotic Linezolid, Microbiology spectrum, 10, e00583, 10.1128/spectrum.00583-22 · DOI
  73. Pillai, 2007, Daptomycin nonsusceptibility in Staphylococcus aureus with reduced vancomycin susceptibility is independent of alterations in MprF, Antimicrobial agents chemotherapy, 51, 2223, 10.1128/AAC.00202-07 · DOI · Paper page
  74. Plata, 2009, Staphylococcus aureus as an infectious agent: overview of biochemistry and molecular genetics of its pathogenicity, Acta Biochim. Pol., 56, 10.18388/abp.2009_2491 · DOI · Paper page
  75. Pozzi, 2012, Methicillin resistance alters the biofilm phenotype and attenuates virulence in Staphylococcus aureus device-associated infections, PLoS Pathog., 8, e1002626, 10.1371/journal.ppat.1002626 · DOI · Paper page
  76. Ribeiro, 2022, Bioinformatics study of expression from genomes of epidemiologically related MRSA CC398 isolates from human and wild animal samples, J. Proteomics, 268, 10.1016/j.jprot.2022.104714 · DOI
  77. Rose, 2007, Evaluation of daptomycin treatment of Staphylococcus aureus bacterial endocarditis: an in vitro and in vivo simulation using historical and current dosing strategies, J. Antimicrob. Chemother., 60, 334, 10.1093/jac/dkm170 · DOI · Paper page
  78. Ruiz-Ripa, 2019, Detection of MRSA of Lineages CC130-mecC and CC398-mecA and Staphylococcus delphini-lnu (A) in Magpies and Cinereous Vultures in Spain, Microb. Ecol., 78, 409, 10.1007/s00248-019-01328-4 · DOI
  79. Sangappa, 2012, Methicillin resistant Staphylococcus aureus: Resistance genes and their regulation, International Journal of Pharmacy, 4, 658
  80. Schriever, 2005, Daptomycin: a novel cyclic lipopeptide antimicrobial, Am. J. Health Syst. Pharm., 62, 1145, 10.1093/ajhp/62.11.1145 · DOI
  81. Stogios, 2020, Molecular mechanisms of vancomycin resistance, Protein Sci., 29, 654, 10.1002/pro.3819 · DOI · Paper page
  82. Tacconelli, 2017, Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development, Protein Sci.
  83. Tally, 2000, Development of daptomycin for gram-positive infections, J. Antimicrob. Chemother., 46, 523, 10.1093/jac/46.4.523 · DOI · Paper page
  84. Tettelin, 2005, Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial “pan-genome”, Proc. Natl. Acad. Sci., 102, 13950, 10.1073/pnas.0506758102 · DOI · Paper page
  85. Thurlow, 2013, Functional modularity of the arginine catabolic mobile element contributes to the success of USA300 methicillin-resistant Staphylococcus aureus, Cell host microbe, 13, 100, 10.1016/j.chom.2012.11.012 · DOI · Paper page
  86. Uhlemann, 2014, Molecular tracing of the emergence, diversification, and transmission of S. aureus sequence type 8 in a New York community, Proc. Natl. Acad. Sci., 111, 6738, 10.1073/pnas.1401006111 · DOI · Paper page
  87. Vestergaard, 2019, Antibiotic resistance and the MRSA problem, Microbiology spectrum, 7, p. 7.2. 18, 10.1128/microbiolspec.GPP3-0057-2018 · DOI · Paper page
  88. Wang, 2010, Roles of CcrA and CcrB in excision and integration of staphylococcal cassette chromosome mec, a Staphylococcus aureus genomic island, J. Bacteriol., 192, 3204, 10.1128/JB.01520-09 · DOI
  89. Weidenmaier, 2005, DltABCD-and MprF-mediated cell envelope modifications of Staphylococcus aureus confer resistance to platelet microbicidal proteins and contribute to virulence in a rabbit endocarditis model, Infect. Immun., 73, 8033, 10.1128/IAI.73.12.8033-8038.2005 · DOI · Paper page
  90. Wilson, 2003, Linezolid resistance in clinical isolates of Staphylococcus aureus, J. Antimicrob. Chemother., 51, 186, 10.1093/jac/dkg104 · DOI · Paper page
  91. Yang, 2010, Cell wall thickening is not a universal accompaniment of the daptomycin nonsusceptibility phenotype in Staphylococcus aureus: evidence for multiple resistance mechanisms, Antimicrobial agents chemotherapy, 54, 3079, 10.1128/AAC.00122-10 · DOI · Paper page
  92. Yang, 2013, Causal role of single nucleotide polymorphisms within the mprF gene of Staphylococcus aureus in daptomycin resistance, Antimicrobial agents chemotherapy, 57, 5658, 10.1128/AAC.01184-13 · DOI
  93. Yoo, 2020, Linezolid resistance in methicillin-resistant Staphylococcus aureus in Korea: High rate of false resistance to linezolid by the VITEK 2 system, Ann. Lab. Med., 40, 57, 10.3343/alm.2020.40.1.57 · DOI
  94. Zarazaga, 2018, Molecular epidemiology of Staphylococcus aureus lineages in the animal–human interface, Staphylococcus aureus, 189, 10.1016/B978-0-12-809671-0.00010-3 · DOI
  95. Zhuang, 2021, A random forest model based on core genome allelic profiles of MRSA for penicillin plus potassium clavulanate susceptibility prediction, Microb. Genomics, 7, 10.1099/mgen.0.000610 · doi:10.1099/mgen.0.000610

Cited by

See all 143

Metadata

Authors
Ali Alghamdi, B., Al-Johani, I., Al-Shamrani, J. M., Musamed Alshamrani, H., Al-Otaibi, B. G., Almazmomi, K., & Yusnoraini Yusof, N.
Venue
Saudi Journal of Biological Sciences
Publisher
Elsevier BV
Published
2023-04
Volume
30
Issue
4
Pages
103604
ISSN
1319-562X
Cited by
143
References
10
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antimicrobial resistance in methicillin-resistant staphylococcus aureus. https://app.cochat.ai/papers/10.1016/j.sjbs.2023.103604
The paper
Ali Alghamdi, B., Al-Johani, I., Al-Shamrani, J. M., Musamed Alshamrani, H., Al-Otaibi, B. G., Almazmomi, K., & Yusnoraini Yusof, N. (2023). Antimicrobial resistance in methicillin-resistant staphylococcus aureus. Saudi Journal of Biological Sciences. https://doi.org/10.1016/j.sjbs.2023.103604

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.